Literature DB >> 15966738

The loop C region of the murine 5-HT3A receptor contributes to the differential actions of 5-hydroxytryptamine and m-chlorophenylbiguanide.

Asha Suryanarayanan1, Prasad R Joshi, Zsolt Bikádi, Muthalagi Mani, Trupti R Kulkarni, Chandra Gaines, Marvin K Schulte.   

Abstract

Sequence and predicted structural similarities between members of the Cys loop superfamily of ligand-gated ion channel receptors and the acetylcholine binding protein (AChBP) suggest that the ligand-binding site is formed by six loops that intersect at subunit interfaces. We employed site-directed mutagenesis to investigate the role of amino acids from the loop C region of the murine 5-HT(3AS)R in interacting with two structurally different agonists, serotonin (5-HT) and m-chlorophenylbiguanide (mCPBG). Mutant receptors were evaluated using radioligand binding, two-electrode voltage clamp, and immunofluorescence studies. Electrophysiological assays were employed to identify changes in response characteristics and relative efficacies of mCPBG and the partial agonist, 2-methyl 5-HT (2-Me5-HT). We have also constructed novel 5-HT and mCPBG docked models of the receptor binding site based on homology models of the AChBP. Both ligand-docked models correlate well with results from mutagenesis and electrophysiological assays. Four key amino acids were identified as being important to ligand binding and/or gating of the receptor. Among these, I228 and D229 are specific for effects mediated by 5-HT compared to mCPBG, indicating a differential interaction of these ligands with loop C. Residues F226 and Y234 are important for both 5-HT and mCPBG interactions. Mutations at F226, I228, and Y234 also altered the relative efficacies of agonists, suggesting a role in the gating mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15966738     DOI: 10.1021/bi050661e

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.

Authors:  M Lochner; S C R Lummis
Journal:  Biophys J       Date:  2010-04-21       Impact factor: 4.033

2.  Unraveling mechanisms underlying partial agonism in 5-HT3A receptors.

Authors:  Jeremías Corradi; Cecilia Bouzat
Journal:  J Neurosci       Date:  2014-12-10       Impact factor: 6.167

3.  Mapping spatial relationships between residues in the ligand-binding domain of the 5-HT3 receptor using a molecular ruler.

Authors:  Heather L Nyce; Spencer T Stober; Cameron F Abrams; Michael M White
Journal:  Biophys J       Date:  2010-05-19       Impact factor: 4.033

Review 4.  Therapeutics of 5-HT3 receptor antagonists: current uses and future directions.

Authors:  Tina K Machu
Journal:  Pharmacol Ther       Date:  2011-02-26       Impact factor: 12.310

5.  Crystal structures of a cysteine-modified mutant in loop D of acetylcholine-binding protein.

Authors:  Marijke Brams; Elaine A Gay; José Colón Sáez; Albert Guskov; René van Elk; Roel C van der Schors; Steve Peigneur; Jan Tytgat; Sergei V Strelkov; August B Smit; Jerrel L Yakel; Chris Ulens
Journal:  J Biol Chem       Date:  2010-11-29       Impact factor: 5.157

6.  Design, synthesis, and structure-activity relationships of highly potent 5-HT₃ receptor ligands.

Authors:  Mark H P Verheij; Andrew J Thompson; Jacqueline E van Muijlwijk-Koezen; Sarah C R Lummis; Rob Leurs; Iwan J P de Esch
Journal:  J Med Chem       Date:  2012-10-12       Impact factor: 7.446

Review 7.  5-HT(3) receptors.

Authors:  Sarah C R Lummis
Journal:  J Biol Chem       Date:  2012-10-04       Impact factor: 5.157

8.  A hydrogen bond in loop A is critical for the binding and function of the 5-HT3 receptor.

Authors:  Kerry L Price; Kiowa S Bower; Andrew J Thompson; Henry A Lester; Dennis A Dougherty; Sarah C R Lummis
Journal:  Biochemistry       Date:  2008-05-22       Impact factor: 3.162

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.